SARAJEVO (Bosnia and Herzegovina), July 11 (SeeNews) – Bosnia’s biggest drug maker, Bosnalijek [SAJ:BSNLR], turned to a loss of 4.7 million marka ($2.95 million/2.4 million euro) in the first quarter of 2012 from a net profit of 1.67 million marka a year earlier, company data indicated.